BRUSSELS (Reuters) - The European Commission said on Thursday it would not take up an option to buy 100 million additional doses of AstraZeneca's COVID-19 vaccine which is included in the current supply contract the EU has with the company.
A spokesman told a news conference that the deadline to exercise the option had already expired and the EU did not plan to take it up, confirming a Reuters report from Wednesday.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!